Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Organigram Global Inc.

OGINASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.42
$0.01(0.71%)
U.S. Market opens in 15h 53m

Organigram Global Inc. (OGI) Stock Overview

Explore Organigram Global Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap191.9M
P/E Ratio14.44
EPS (TTM)$0.11
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$1.40
3 Months$1.48
1 Year Target$1.52

OGI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Organigram Global Inc. (OGI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.22, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.44 and a market capitalization of 191.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.71%
5-Day Change
-2.07%
1-Month Change
11.81%
3-Month Change
-27.55%
6-Month Change
-19.32%
Year-to-Date (YTD) Change
-17.92%
1-Year Change
32.71%
3-Year Change
-45.38%
5-Year Change
-91.32%
All-Time (Max) Change
-95.45%

Contact Information

15063841571
35 English Drive, Moncton, NB, E1E 3X3

Company Facts

10,930 Employees
IPO DateMay 21, 2019
CountryCA
Actively Trading

Frequently Asked Questions